Baxter International Inc. (BAX) To Go Ex-Dividend on May 29th

Baxter International Inc. (NYSE:BAX) declared a quarterly dividend on Wednesday, April 29th. Shareholders of record on Friday, May 29th will be given a dividend of 0.01 per share by the medical instruments supplier on Wednesday, July 1st. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, May 29th.

Baxter International has decreased its dividend by an average of 0.1%annually over the last three years. Baxter International has a dividend payout ratio of 1.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Baxter International to earn $1.97 per share next year, which means the company should continue to be able to cover its $0.04 annual dividend with an expected future payout ratio of 2.0%.

Baxter International Trading Up 1.3%

NYSE:BAX opened at $19.42 on Wednesday. Baxter International has a 1-year low of $15.73 and a 1-year high of $32.04. The business’s 50-day moving average price is $17.54 and its two-hundred day moving average price is $18.75. The company has a current ratio of 1.85, a quick ratio of 1.23 and a debt-to-equity ratio of 1.43. The firm has a market capitalization of $10.03 billion, a price-to-earnings ratio of -9.12, a PEG ratio of 3.09 and a beta of 0.62.

Baxter International (NYSE:BAX) last released its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.36 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.05. Baxter International had a positive return on equity of 16.15% and a negative net margin of 9.70%.The firm had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.62 billion. During the same quarter in the prior year, the firm posted $0.62 earnings per share. The company’s quarterly revenue was up 2.9% on a year-over-year basis. On average, equities analysts expect that Baxter International will post 1.92 earnings per share for the current year.

Institutional Investors Weigh In On Baxter International

Hedge funds and other institutional investors have recently bought and sold shares of the company. Imprint Wealth LLC acquired a new stake in Baxter International in the 3rd quarter valued at approximately $27,000. Basepoint Wealth LLC acquired a new stake in Baxter International in the 4th quarter valued at approximately $26,000. MUFG Securities EMEA plc acquired a new stake in Baxter International in the 2nd quarter valued at approximately $46,000. Los Angeles Capital Management LLC acquired a new stake in Baxter International in the 4th quarter valued at approximately $46,000. Finally, McMillan Office Inc. acquired a new stake in Baxter International in the 4th quarter valued at approximately $54,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.